203 related articles for article (PubMed ID: 26685322)
1. Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.
Lee JA; Paik EK; Seo J; Kim DH; Lim JS; Yoo JY; Kim MS
Jpn J Clin Oncol; 2016 Feb; 46(2):138-43. PubMed ID: 26685322
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and docetaxel for the treatment of children and adolescents with recurrent or refractory osteosarcoma: Korea Cancer Center Hospital experience.
Song BS; Seo J; Kim DH; Lim JS; Yoo JY; Lee JA
Pediatr Blood Cancer; 2014 Aug; 61(8):1376-81. PubMed ID: 24692087
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.
Qi WX; He AN; Tang LN; Shen Z; Lin F; Yao Y
Jpn J Clin Oncol; 2012 May; 42(5):427-31. PubMed ID: 22450929
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.
He A; Qi W; Huang Y; Sun Y; Shen Z; Zhao H; Yang Y; Yao Y
Int J Clin Oncol; 2013 Jun; 18(3):498-505. PubMed ID: 22534798
[TBL] [Abstract][Full Text] [Related]
5. Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.
Lee JA; Jeon DG; Cho WH; Song WS; Yoon HS; Park HJ; Park BK; Choi HS; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Koh KN; Im HJ; Seo JJ; Lim YJ; Baek HJ; Kook H
Pediatr Blood Cancer; 2016 Sep; 63(9):1552-6. PubMed ID: 27197055
[TBL] [Abstract][Full Text] [Related]
6. The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
Xiao X; Wang W; Wang Z
Paediatr Drugs; 2014 Dec; 16(6):503-12. PubMed ID: 25392156
[TBL] [Abstract][Full Text] [Related]
7. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.
Navid F; Willert JR; McCarville MB; Furman W; Watkins A; Roberts W; Daw NC
Cancer; 2008 Jul; 113(2):419-25. PubMed ID: 18484657
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study.
Hara H; Kawamoto T; Fukase N; Kawakami Y; Takemori T; Fujiwara S; Kitayama K; Nishida K; Kuroda R; Akisue T
BMC Cancer; 2019 Jul; 19(1):725. PubMed ID: 31337342
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone.
Palmerini E; Jones RL; Marchesi E; Paioli A; Cesari M; Longhi A; Meazza C; Coccoli L; Fagioli F; Asaftei S; Grignani G; Tamburini A; Pollack SM; Picci P; Ferrari S
BMC Cancer; 2016 Apr; 16():280. PubMed ID: 27098543
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
Fox E; Patel S; Wathen JK; Schuetze S; Chawla S; Harmon D; Reinke D; Chugh R; Benjamin RS; Helman LJ
Oncologist; 2012; 17(3):321. PubMed ID: 22363068
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: the experience at Children's Memorial Hospital.
Gosiengfiao Y; Reichek J; Woodman J; Ben-Ami T; Walterhouse D
J Pediatr Hematol Oncol; 2012 Mar; 34(2):e63-5. PubMed ID: 22217487
[TBL] [Abstract][Full Text] [Related]
12. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Xu J; Guo W; Xie L
BMC Cancer; 2018 Oct; 18(1):987. PubMed ID: 30326879
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.
Lee EM; Rha SY; Lee J; Park KH; Ahn JH
Cancer Chemother Pharmacol; 2012 Mar; 69(3):635-42. PubMed ID: 21959979
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients.
Tanaka K; Joyama S; Chuman H; Hiraga H; Morioka H; Yoshikawa H; Hosaka M; Takahashi M; Kubo T; Hatano H; Kaya M; Toguchida J; Nishida Y; Nagano A; Tsumura H; Iwamoto Y
World J Surg Oncol; 2016 Dec; 14(1):306. PubMed ID: 27931230
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon B; Strauss SJ; Whelan J; Leahy M; Woll PJ; Cowie F; Rothermundt C; Wood Z; Benson C; Ali N; Marples M; Veal GJ; Jamieson D; Küver K; Tirabosco R; Forsyth S; Nash S; Dehbi HM; Beare S
Lancet Oncol; 2017 Oct; 18(10):1397-1410. PubMed ID: 28882536
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis.
Takahashi M; Komine K; Imai H; Okada Y; Saijo K; Takahashi M; Shirota H; Ohori H; Takahashi S; Chiba N; Mori T; Shimodaira H; Ishioka C
PLoS One; 2017; 12(5):e0176972. PubMed ID: 28489919
[TBL] [Abstract][Full Text] [Related]
17. [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Ito T; Mochida A; Saito K; Nishi K; Sasaki S; Hisada T; Morinari H; Nakahara K; Tahara M; Masuda S; Yakumaru K
Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):71-6. PubMed ID: 11925923
[TBL] [Abstract][Full Text] [Related]
18. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
Mora J; Castañeda A; Perez-Jaume S; Lopez-Pousa A; Maradiegue E; Valverde C; Martin-Broto J; Garcia Del Muro X; Cruz O; Cruz J; Martinez-Trufero J; Maurel J; Vaz MA; de Alava E; de Torres C
Br J Cancer; 2017 Sep; 117(6):767-774. PubMed ID: 28787430
[TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel.
Mora J; Cruz CO; Parareda A; de Torres C
J Pediatr Hematol Oncol; 2009 Oct; 31(10):723-9. PubMed ID: 19727011
[TBL] [Abstract][Full Text] [Related]
20. Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma.
Lee MY; Jung KS; Kim HS; Lee JY; Lim SH; Kim M; Jung HA; Kim SM; Sun JM; Ahn MJ; Lee J; Park SH; Yi SY; Hwang IG; Lee SC; Ahn HK; Lim DH; Lee SI; Park KW
World J Gastroenterol; 2015 Apr; 21(14):4268-74. PubMed ID: 25892878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
